Evidence map›Paper›PMID 40642994›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

High-frequency oscillations >250 Hz in people with Down syndrome and associated Alzheimer's disease dementia.

Christos Panagiotis Lisgaras, Sandra Giménez, María Carmona-Iragui, Lucia Maure-Blesa, Esther Blessing, Juan Fortea, Ricardo S Osorio

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Tracking electrophysiological signatures of Alzheimer's disease: a systematic review of multimodal studies.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Pooled it
  2. Review
  3. Decoding the mechanisms of amyloid-β in synaptic toxicity.Journal of Alzheimer's disease : JAD · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. High-frequency oscillations >250 Hz in people with Down syndrome and associated Alzheimer's disease dementia.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Christos Panagiotis LisgarasDepartment of Psychiatry, New York University Grossman School of Medicine, New York, New York, USA.ORCID 0000-0003-3712-5993
Sandra GiménezMultidisciplinary Sleep Unit, Respiratory Department, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Barcelona, Spain.
María Carmona-IraguiSant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Lucia Maure-BlesaSant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Esther BlessingDepartment of Psychiatry, New York University Grossman School of Medicine, New York, New York, USA.
Juan ForteaSant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Ricardo S OsorioDepartment of Psychiatry, New York University Grossman School of Medicine, New York, New York, USA.

Funding

Research Education ComponentP30AG066512 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Mary Sherman Mittelman · 2020 to 2026
$28.4M
DS-ARC: A Remote Digital Cognitive Assessment for Down Syndrome-Associated Alzheimer's DiseaseR01AG081394 · NIA · WASHINGTON UNIVERSITY · PI Jason J Hassenstab · 2023 to 2026
$6.0M
The Role of Inflammation and NGF Dysfunction in the Evolution of Alzheimer Disease Pathology in Down Syndrome-RevisionRF1AG056850 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI BUSCIGLIO, JORGE A, CUELLO, A CLAUDIO · 2018 to 2020
$5.9M
Clinical trials to prevent Alzheimer's Disease in Down SyndromeR61AG066543 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI RAFII, MICHAEL S · 2019 to 2020
$5.6M
Tau pathology in Down syndrome and Alzheimer'sRF1AG061566 · NIA · UNIVERSITY OF DENVER (COLORADO SEMINARY) · PI GRANHOLM-BENTLEY, ANN-CHARLOTTE ESTHER, MARGITTAI, MARTIN · 2019 to 2019
$3.4M
Sleep and Temperature Disturbance as risk factors for Alzheimer's Disease in Down Syndrome: a Longitudinal StudyRF1AG080769 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BLESSING, ESTHER MARIAN, FORTEA, JUAN · 2023 to 2023
$1.9M
High frequency oscillations in Alzheimer's diseaseR21AG086880 · NIA · NATHAN S. KLINE INSTITUTE FOR PSYCH RES · PI LISGARAS, CHRISTOS PANAGIOTIS · 2024 to 2024
$454k
Biological Correlates of Alzheimer in Down Syndrome.R21AG056974 · NIA · UNIVERSITY OF DENVER (COLORADO SEMINARY) · PI GRANHOLM-BENTLEY, ANN-CHARLOTTE ESTHER · 2017 to 2018
$414k
Alzheimer's Association AARG-22-973966Fondo Europeo de Desarrollo RegionalFundación Tatiana Pérez de Guzmán el Bueno IIBSP-DOW-2020-151Global Brain Health Institute GBHI_ALZ-18-543740Global Brain Health Institute GBHI_ALZ-23-971107Horizon 2020-Research and Innovation Framework Programme of the European Union H2020-SC1-BHC-2018-2020Instituto de Salud Carlos III CM22/00291Instituto de Salud Carlos III ICI23/00032Instituto de Salud Carlos III INT21/00073Instituto de Salud Carlos III PI18/00335Instituto de Salud Carlos III PI20/00836Instituto de Salud Carlos III PI20/01473Instituto de Salud Carlos III PI22/00758Instituto de Salud Carlos III PI23/01786Jérôme Lejeune Foundation 1801Jérôme Lejeune Foundation 1913NIA NIH HHS P30 AG066512NIA NIH HHS R01 AG081394NIA NIH HHS R21 AG056974NIA NIH HHS R21 AG086880NIA NIH HHS R21AG086880NIA NIH HHS R61 AG066543NIA NIH HHS RF1 AG056850NIA NIH HHS RF1 AG061566NIA NIH HHS RF1 AG080769NIH HHS R01AG056850NIH HHS R01AG061566NIH HHS R01AG081394NIH HHS R21AG056974NIH HHS R61AG066543NIH HHS RF1AG080769Societat Catalana de Neurologia SCN2020
6 · The paper itself

Abstract

introductionAlzheimer's disease (AD) dementia has near full penetrance in adults with Down syndrome (DS) and is strongly linked to late-onset myoclonic epilepsy in Down syndrome (LOMEDS). However, promising biomarkers of epileptogenicity, such as high-frequency oscillations (HFOs >250 Hz), have not been studied. This study is the first to use wideband polysomnography in DS to investigate if HFOs occurred and preceded AD dementia and LOMEDS.

methodsWideband (0.1 to 500 Hz, 2048 Hz) polysomnography was performed using the international 10-20 system. HFOs were automatically detected during slow-wave sleep, followed by manual review.

resultsFourteen individuals with DS and five age-matched euploid controls were studied, with all DS cases showing HFOs. HFOs emerged before AD dementia and LOMEDS and showed hemispheric lateralization in asymptomatic but not symptomatic AD dementia cases. A trend toward increasing HFO rates with age in DS warrants further confirmation. DISCUSSION: HFOs are promising biomarkers that may predict symptomatic AD dementia in adults with DS. HIGHLIGHTS: Wideband polysomnography reveals a new electrical abnormality in DS. HFOs precede AD dementia in DS. The occurrence of HFOs in DS is independent of an epilepsy diagnosis. HFOs showed hemispheric lateralization in asymptomatic DS cases. A trend of increased HFO rate with advancing age warrants further investigation.

Indexed as

Alzheimer DiseaseBrain WavesDown SyndromeEpilepsies, MyoclonicAdultAgedBrainElectroencephalographyFemaleHumansMaleMiddle AgedPolysomnographyAlzheimer's diseaseamyloidbiomarkerDown syndromeelectroencephalographyinterictalseizuressleep

Identifiers

PMID40642994
PMCPMC12246959

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.